EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Decoding functional impact of epigenetic regulator mutations on ligand–receptor interaction perturbations for evaluation of cancer immunotherapy

Aiai Shi, Chaohuan Lin, Jie Lyu iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.70009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Aiai Shi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Joint Centre of Translational Medicine, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, People's Republic of China. Hauptthemen laut MEDLINE: Immunotherapy, Mutation, Neoplasms, Epigenesis, Genetic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wenzhou Institute, University of Chinese Academy of Sciences' startup fund, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular crosstalk mediated by ligand–receptor interactions largely complicates the tumour ecosystem, resulting in heterogeneous tumour microenvironments that affect immune response and clinical benefits from immunotherapy. Epigenetic mechanisms are pivotal to expression changes of immune‐related genes and can modulate the anti‐tumour immune response. However, the functional consequences of disrupted epigenetic regulators (ERs) on ligand–receptor interactions in the tumour microenvironment remain largely unexplored. Here, we proposed mutations of ERs in perturbed interactions (MERIN), a molecular network‐based approach that incorporates multi‐omics data, to infer the potential consequences of ER mutations on ligand–receptor interaction perturbations. Leveraging cancer genomic profiles and molecular interaction data, we comprehensively decoded the functional consequences of ER mutations on dysregulated ligand–receptor interactions across 33 cancers. The dysregulated ligand–receptor genes were indeed enriched in cancer and immune‐related function. We demonstrated the potential significance of PD1–PDL1 interaction‐related ER mutations in stratifying cancer patients from multiple independent data cohorts. The ER mutation group showed distinct immunological characterizations and prognoses. Furthermore, we highlighted that the ER mutations could potentially predict clinical outcomes of immunotherapy. Our computational and clinical assessment underscore the utility of MERIN for elucidating the functional relevance of ER mutations in cancer immune response, potentially aiding patients' stratification for immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyMutationNeoplasmsEpigenesis, GeneticTumor MicroenvironmentGene Expression Regulation, NeoplasticHumansB7-H1 AntigenLigandsProgrammed Cell Death 1 ReceptorPrognosisComputational Biology

Stichwörter der Autor:innen

cancerepigenetic regulatorimmuneimmunotherapyligand–receptor interactionmutation

Substanzen

B7-H1 AntigenLigandsProgrammed Cell Death 1 ReceptorCD274 protein, humanPDCD1 protein, human

Autor:innen und Institutionen

  • Joint Centre of Translational Medicine, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, People's Republic of China.
  • Institute of Theoretical Physics, Chinese Academy of Sciences, Beijing, People's Republic of China.
  • Joint Centre of Translational Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
  • Postgraduate Training Base Alliance of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
  • Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou, Zhejiang, People's Republic of China.

ORCID-Profile: Jie Lyu

Förderung

  • Wenzhou Institute, University of Chinese Academy of Sciences' startup fund
  • National Natural Science Foundation of China

Zitieren

APA

Shi, A., Lin, C., & Lyu, J. (2024). Decoding functional impact of epigenetic regulator mutations on ligand–receptor interaction perturbations for evaluation of cancer immunotherapy. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70009

Vancouver

Shi A, Lin C, Lyu J. Decoding functional impact of epigenetic regulator mutations on ligand–receptor interaction perturbations for evaluation of cancer immunotherapy. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70009

BibTeX
@article{Shi2024,
  author = {Shi, Aiai and Lin, Chaohuan and Lyu, Jie},
  title = {Decoding functional impact of epigenetic regulator mutations on ligand–receptor interaction perturbations for evaluation of cancer immunotherapy},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.70009}
}
Kostenlos starten →